tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

PFEPfizer

Health care · Pharmaceuticals · NYSE
Compare with peers → Embed
Revised numbers, fiscal years since 2020

4 numbers reported differently in a later 10-K

XBRL, 6 10-Ks
Numbers revised
4
changes of 0.5% or more
Restatements
0
the company said the earlier number was wrong (8-K item 4.02)
Largest change
-9.4%
Revenue, Fiscal year ending 2021-12-31

A change is a restatement (the company says the earlier number was wrong) or a recast: after selling a business, adopting an accounting rule or moving amounts between lines, companies redo past years. The later 10-K's notes say which.

Number by number

First reported, then reported again

Each number links to its 10-K
NumberPeriodFirst reportedLater reportedChangeWhy
Receivables
AccountsReceivableNetCurrent · link
At 2023-12-31 $11.18B
10-K filed 2024-02-22
$11.57B
10-K filed 2025-02-27
+3.5% Recast or revision
Revenue
RevenueFromContractWithCustomerExcludingAssessedTax · link
Fiscal year ending 2021-12-31 $81.29B
10-K filed 2022-02-24
$73.64B
10-K filed 2024-02-22
-9.4% Recast or revision
Revenue
RevenueFromContractWithCustomerExcludingAssessedTax · link
Fiscal year ending 2020-12-31 $41.91B
10-K filed 2021-02-25
$41.65B
10-K filed 2022-02-24
-0.6% Recast or revision
Net income
NetIncomeLoss · link
Fiscal year ending 2020-12-31 $9.62B
10-K filed 2021-02-25
$9.16B
10-K filed 2022-02-24
-4.8% Recast or revision

From SEC's XBRL company facts (6 10-K filings). Checked: revenue, operating income, net income, cash from operations, total assets, shareholders' equity, receivables and inventory. Per-share numbers are left out because stock splits change them.

Next Footnotes →